Intervention

Phentermine-Topiramate

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting2

Common conditions7

Lead sponsors shown4

Clinical trials

5 shown

Individualized Pharmacological Approach to Obesity in Patients With Bipolar DisorderNCT07213466 · 2026-01-19

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsNCT04721873 · 2020-12-18

Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)NCT06854614 · 2025-03-01

ACTIVE_NOT_RECRUITING

Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe ObesityNCT04298203 · 2021-08-04

Individualized Obesity PharmacotherapyNCT03374956 · 2017-12-11

Common conditions

Obesity5 Bipolar I Disorder1 Bipolar II Disorder1 Colitis, Ulcerative1 GLP - 11 Schizo Affective Disorder1 Weight Loss1

Leading sponsors

Mayo Clinic2 The Cleveland Clinic1 University of California, San Diego1 University of Minnesota1

Trial status mix

COMPLETED2

RECRUITING2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE22

PHASE42

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.